Research.Patient.info
Advanced Urothelial Cancer research hub
2 indexed studies · 1 currently recruiting
- ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations
This study looks at a new drug, erdafitinib, for people with advanced bladder cancer that has a specific gene change. It compares erdafitinib to standard treatments like pembrolizumab, docetaxel, or vinflunine to see if it helps people live longer.
France · Spain · Belgium - recruitingPHASE2
Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers
This study aims to understand why some cancer treatments, called ADCs, stop working. By looking at samples from patients with advanced breast, stomach, bladder, or lung cancer, researchers hope to find better ways to choose the right ADC for each person and reduce side effects.
France